The effect of multivitamin and mineral complex on natural killer cell activity in surgically resected non-small cell lung cancer patients: A randomized, double-blind placebo-controlled study

被引：0
|
作者：
Kim, Jiwon [1 ,2 ]
Choi, Chang-Min [2 ,3 ]
Kim, Hyeong Ryul [4 ]
Lee, Geun Dong [4 ]
Gil, Minchan [5 ]
Lee, Hyeja [5 ]
Kim, Hye Rim [5 ]
Ji, Wonjun [2 ]
Lee, Seung Hyeun [1 ]
机构：
[1] Kyung Hee Univ Hosp, Resp Allergy & Crit Care Med, Seoul, South Korea
[2] Asan Med Ctr, Pulm & Crit Care Med, Seoul, South Korea
[3] Asan Med Ctr, Oncol, Seoul, South Korea
[4] Asan Med Ctr, Thorac & Cardiovasc Surg, Seoul, South Korea
[5] NKMAX Co Ltd, Lib Planning & Management, Seongnam, South Korea
来源：
RESPIROLOGY | 2023年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
AP08-345
引用
收藏
页码：322 / 322
页数：1
相关论文
共 50 条
  • [21] Efficacy of a natural mineral complex in North American adults with osteoarthritis of the knee: a randomized double-blind placebo-controlled study
    Evans, Malkanthi
    Wilson, Dale
    Guthrie, Najla
    OPEN ACCESS RHEUMATOLOGY-RESEARCH AND REVIEWS, 2014, 6 : 91 - 103
  • [22] Prognostic factors for recurrence in patients with surgically resected non-small cell lung cancer
    Satoh, Hiroaki
    Iguchi, Kesato
    Nakamura, Ryota
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2022, 26 (04): : 314 - 314
  • [23] Prognostic factors for recurrence in patients with surgically resected non-small cell lung cancer
    Moskalenko, Yuliia
    Smorodska, Olga
    Deineka, Volodymyr
    Kravets, Oleksandr
    Moskalenko, Roman
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2022, 26 (03): : 239 - 246
  • [24] Phase II/III clinical trial of randomized, double-blind, placebo-controlled combined with recombinant human endostatin in treatment of advanced non-small cell lung cancer
    Xu Liyan
    Shi He Heling
    Liu Zhe
    Zhu Yunzhong
    Li Baolan
    Zhang Shucai
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S354 - S354
  • [25] Analyses on the Clinical Usefulness of Natural Killer Cell Activity in Non-Small Cell Lung Cancer Patients
    Choi, Sue In
    In, Kwnag Ho
    Kang, Kyung Ho
    Shim, Jae Jeong
    Shin, Chol
    Lee, Sang Yeub
    Kim, Je Hyeong
    Lee, Sung Yong
    Lee, Seung Heon
    Hur, Gyu Young
    Min, Kyung Hoon
    Lee, Eun Joo
    Jung, Won Jai
    CHEST, 2017, 152 (04) : 663A - 663A
  • [26] IMMUNOLOGICAL STUDIES IN A DOUBLE-BLIND RANDOMIZED TRIAL COMPARING INTRAPLEURAL BCG AGAINST PLACEBO IN PATIENTS WITH RESECTED STAGE-I NON-SMALL CELL LUNG-CANCER
    OLDHAM, RK
    GAIL, MH
    BAKER, MA
    FORBES, JT
    HEINEMAN, W
    HERSH, E
    HOLMES, EC
    RITTS, RE
    WRIGHT, PW
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1982, 13 (03) : 164 - 173
  • [27] PACIFIC: A Double-Blind, Placebo-Controlled Phase 3 Study of Durvalumab as Consolidation Therapy After Chemoradiation in Patients with Locally Advanced, Unresectable Non-Small Cell Lung Cancer
    Antonia, S. J.
    Villegas, A.
    Daniel, D.
    Baz, D. Vincente
    Murakami, S.
    Hui, R.
    Yokoi, T.
    Chiappori, A.
    Lee, K. H.
    de Wit, M.
    Cho, B. C.
    Bourhaba, M.
    Quantin, X.
    Tokito, T.
    Mekhail, T.
    Planchard, D.
    Jiang, H.
    Huang, Y.
    Dennis, P. A.
    Ozguroglu, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (05): : 1314 - 1315
  • [28] A multicenter, randomized, double-blind, placebo-controlled study to evaluate the clinical effects of pacilitaxel-carboplatin (TC) alone or with endostatin for advanced non-small cell lung cancer (NSCLC)
    Han, B.
    Xiu, Q.
    Luo, Y.
    Bai, C.
    Guo, S.
    Liu, W.
    Zhuang, Z.
    Zhang, Y.
    Zhou, J.
    Jin, X.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [29] A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Oral Talactoferrin in Combination with Carboplatin and Paclitaxel in Previously Untreated Locally Advanced or Metastatic Non-small Cell Lung Cancer
    Digumarti, Raghunadharao
    Wang, Yenyun
    Raman, Ganapathi
    Doval, Dinesh C.
    Advani, Suresh H.
    Julka, Pramod K.
    Parikh, Purvish M.
    Patil, Shekhar
    Nag, Shona
    Madhavan, Jayaprakash
    Bapna, Ajay
    Ranade, Annantbhushan A.
    Varadhachary, Atul
    Malik, Rajesh
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : 1098 - 1103
  • [30] DAILY ORAL PERIFOSINE IN COMBINATION WITH RADIOTHERAPY IN LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER: FIRST RESULTS OF A RANDOMIZED DOUBLE-BLIND, PLACEBO-CONTROLLED MULTICENTER PHASE II STUDY
    Verheij, M.
    Karchmit, Y.
    Bakardjiev, S.
    Beliaukouski, V.
    Savu, M.
    Smickoska, S.
    Sindermann, H.
    Markivskyy, A.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S167 - S167
12345